Filing Flows › Profound Medical (PROF) › Recurring - non-capital revenue
Profound Medical (PROF) Recurring - non-capital revenue by quarter
Profound Medical's Recurring - non-capital revenue was $4.1M in Q3 2026 (third quarter 2026), +155% from Q2 2026. Over the last 7 quarters it ranged from $1.6M (Q2 2025) to $4.1M (Q3 2026).
| Quarter | Recurring - non-capital revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $4.1M | +155% | +1% |
| Q2 2026 | $1.6M | -35% | +3% |
| Q1 2026 | $2.5M | +7% | +37% |
| Q4 2025 | $2.3M | -43% | — |
| Q3 2025 | $4.1M | +160% | — |
| Q2 2025 | $1.6M | -13% | — |
| Q1 2025 | $1.8M | — | — |
Q3 2026 at a glance
Profound Medical, Q3 2026: revenue $9.8M (+86% year over year), operating margin -79.6%, net loss $7.7M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Profound Medical's Recurring - non-capital revenue?
Profound Medical's Recurring - non-capital revenue was $4.1M in Q3 2026 (third quarter 2026), +155% from Q2 2026.
How has Profound Medical's Recurring - non-capital revenue changed?
Over the last 7 quarters it ranged from $1.6M (Q2 2025) to $4.1M (Q3 2026).